Recent advances in the treatment of choroideremia include in vivo gene augmentation therapy. The disease is well suited for gene therapy approaches due to, amongst other factors, the accessibility ...

Gene therapy is used to treat large number of diseases. Research in the field of human gene therapy is directed towards correcting genetic defects of somatic cells i.e., cells that do not ...

New Delhi, Jan. 02, 2025 (GLOBE NEWSWIRE) -- The global gene therapy market was valued at US$ 9.42 billion in 2024 and is projected to hit the market valuation of US$ 42.26 billion by 2033 at a CAGR ...

That effort is led by OCU400, a gene augmentation therapy for patients with inherited retinal diseases (IRDs) caused by mutations in the NR2E3 gene. OCU400 recently received orphan drug ...

Luton, Bedfordshire, United Kingdom, Dec. 26, 2024 (GLOBE NEWSWIRE) -- Gene Therapy Market Analysis: A Paradigm Shift in Modern Medicine Gene therapy, a transformative approach to treating ...

Technological Advancements : Ongoing innovations in gene delivery methods, such as the development of next-generation viral and non-viral vectors, are expected to drive substantial growth in the gene ...